Inhibition of factor Xa-induced platelet aggregation by a selective thrombin inhibitor, argatroban
- 1 May 1994
- journal article
- Published by Elsevier in Thrombosis Research
- Vol. 74 (3) , 185-191
- https://doi.org/10.1016/0049-3848(94)90107-4
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Comparative effects of aspirin, a synthetic thrombin inhibitor and a monoclonal antiplatelet glycoprotein IIb/IIIa antibody on coronary artery reperfusion, reocclusion and bleeding with recombinant tissue-type plasminogen activator in a canine preparationJournal of the American College of Cardiology, 1990
- Clot-bound thrombin is protected from inhibition by heparin-antithrombin III but is susceptible to inactivation by antithrombin III-independent inhibitors.Journal of Clinical Investigation, 1990
- Prevention of platelet-rich arterial thrombosis by selective thrombin inhibition.Circulation, 1989
- Thrombin is an important mediator of platelet aggregation in stenosed canine coronary arteries with endothelial injury.Journal of Clinical Investigation, 1989
- Selective inhibition of thrombin by (2R,4R)-4-methyl-1-[N2-[1,2,3,4-tetrahydro-8-quinolinyl)sulfonyl]-L-arginyl]-2-piperidinecarboxylic acidBiochemistry, 1984
- Protection of factor Xa from neutralization by the heparin-antithrombin complex.Journal of Clinical Investigation, 1983
- The multiple complexes formed by the interaction of platelet factor 4 with heparinBiochemical Journal, 1980
- The Activation of Prothrombin by Platelet-Bound Factor XaEuropean Journal of Biochemistry, 1980
- Aggregation of Blood Platelets by Adenosine Diphosphate and its ReversalNature, 1962